What is the first diagnostic step for an undescended testis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

First Diagnostic Step for Undescended Testis

The first and most critical diagnostic step for undescended testis is a thorough physical examination to determine whether the testis is palpable or nonpalpable—this single clinical finding dictates all subsequent management, and imaging studies provide no additional diagnostic benefit. 1

Clinical Examination is Definitive

The 2025 EAU/ESPU guidelines are unequivocal: medical history and physical examination are key in evaluating boys with undescended testis, and localization studies using different imaging modalities usually provide no additional benefit 1. This represents the highest quality current evidence and should guide practice.

What to Look for on Physical Examination:

The examination must classify the testis as either:

  • Palpable (can be felt along the normal path of descent)
  • Nonpalpable (cannot be felt anywhere)

This distinction is critical because:

  • Palpable testes proceed directly to standard orchidopexy 1
  • Nonpalpable testes require laparoscopy for definitive diagnosis and treatment planning 1

Examination Technique:

Perform the examination in a warm room with the child relaxed. Examine from the external inguinal ring down to the scrotum, attempting to manipulate any palpable testis toward the scrotum. Distinguish true undescended testis from retractile testis (which can be manipulated into the scrotum and remains there temporarily).

Why Imaging is Not Recommended

The guidelines explicitly state that imaging modalities provide no additional benefit 1. This is reinforced by research evidence showing that ultrasound cannot reliably locate nonpalpable testes or change management decisions 2, 3. The "Choosing Wisely Canada" campaign specifically included avoidance of ultrasound in evaluating undescended testes 3.

Common Pitfall to Avoid:

Do not delay referral to obtain ultrasound or other imaging. This wastes time during the critical window for intervention (6-18 months of age) when germ cell loss is progressive 1.

Clinical Urgency

Once the diagnosis is made by physical examination:

  • Referral should occur by 6 months of age (corrected for prematurity) 1, 3
  • Treatment must be completed by 12 months, or 18 months at the absolute latest 1
  • This timing is critical because histological damage (germ cell and Leydig cell loss) is already evident by 12-18 months 1

The rationale for early intervention is to preserve fertility potential and reduce malignancy risk—both directly impact long-term morbidity and quality of life 1, 2.

Re-examination Under Anesthesia

For nonpalpable testes, an important diagnostic step occurs intraoperatively: thorough re-examination under general anesthesia may identify a previously nonpalpable testis, which changes the surgical approach from laparoscopy to standard orchidopexy 1.

Related Questions

Is there any role for testicular ultrasound in evaluating an undescended testis in an 8-month-old infant?
What condition causes an infant's testis to be pulled upward and become absent from the scrotum?
How should a 9-year-old boy with unilateral undescended testis and a short penile shaft be evaluated and managed, and what criteria define a micropenis?
Is it possible for testes (testicles) to be palpable at 12 months and then not palpable at 15 months?
How should a 20‑month‑old boy with bilateral non‑palpable testes, an empty left scrotum, a right communicating hydrocele, and inconclusive ultrasound be evaluated and managed—including the reliability of ultrasound for intra‑abdominal testes, the role of endocrine testing (anti‑Müllerian hormone, inhibin B, luteinizing hormone, follicle‑stimulating hormone, testosterone), indications for karyotyping, the need for examination under anesthesia and diagnostic laparoscopy, criteria for single‑stage orchidopexy versus staged Fowler‑Stephens orchiopexy, intra‑operative decision‑making for various testicular locations, and optimal timing of surgical intervention?
One month after a STEMI, should my female patient continue fondaparinux sodium 2.5 mg daily, or discontinue it and use other antiplatelet/anticoagulant therapy?
What could be the cause of an elevated anti‑Müllerian hormone (AMH) level in a 36‑year‑old woman with endometriosis who is taking Visanne (dienogest)?
How should therapeutic anticoagulation be administered in a 77‑kg patient with unstable angina and a TIMI risk score of 4?
If the patient is readmitted, should we restart the medication?
Can an 8-year-old child be given Augmentin (amoxicillin‑clavulanate) 375 mg three times daily?
How should a patient with a documented or strongly suspected vancomycin allergy be managed, including alternative antibiotics and desensitization options?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.